SCHEMBL1680382

SCHEMBL1680382

OCc1cccc(Sc2ccccc2)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 2/20 0.61
HTR6 P50406 1/20 0.61
TSHR P16473 1/20 0.52
PRKCI P41743 1/20 0.44
ENPP2 Q13822 1/20 0.44
CFTR P13569 1/20 0.43
SLC6A4 P31645 1/20 0.43
PRSS1 P07477 1/20 0.41
PRSS2 P07478 1/20 0.41
PRSS3 P35030 1/20 0.41
DDB1 Q16531 1/20 0.41
CRBN Q96SW2 1/20 0.41
RHEB Q15382 1/20 0.41
MAOA P21397 1/20 0.40
MAOB P27338 1/20 0.40
BCL2 P10415 1/20 0.40
MCL1 Q07820 1/20 0.40
TOP2A P11388 1/20 0.39
TOP2B Q02880 1/20 0.39
HPGD P15428 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4938425 0.85 PRKCI (0.61) HTR2CHTR6PRKCIENPP2PRSS1
SCHEMBL19116399 0.83 HTR2C (0.45) HTR2CHTR6PRKCIENPP2SLC6A4
SCHEMBL20126552 0.81 HTR2C (0.63) HTR2CHTR6SLC6A4PRSS1PRSS2
SCHEMBL3167912 0.81 MAOB (0.58) HTR2CHTR6PRKCIDDB1CRBN
SCHEMBL3195728 0.81 HDAC3 (0.48) HTR2CHTR6TSHRPRKCIENPP2
SCHEMBL23034574 0.81 HTR2C (0.46) HTR2CHTR6PRKCIENPP2SLC6A4
SCHEMBL2240656 0.81 HTR2C (0.42) HTR2CHTR6PRKCISLC6A4DDB1
SCHEMBL5761245 0.80 TSHR (0.59) HTR2CHTR6TSHRSLC6A4RHEB
SCHEMBL16935701 0.80 ENPP2 (0.48) HTR2CHTR6TSHRPRKCIENPP2
SCHEMBL3902642 0.80 MAOA (0.50) TSHRENPP2CFTRSLC6A4PRSS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110195999-A1 NOVEL ANTIFUNGAL AGENT CONTAINING HETEROCYCLIC COMPOUND NAKAMOTO KAZUTAKA 2011-08-11 US disclosed
US-20110195999-A1 NOVEL ANTIFUNGAL AGENT CONTAINING HETEROCYCLIC COMPOUND NAKAMOTO KAZUTAKA 2011-08-11 US disclosed
US-20110195999-A1 NOVEL ANTIFUNGAL AGENT CONTAINING HETEROCYCLIC COMPOUND NAKAMOTO KAZUTAKA 2011-08-11 US disclosed
US-7932272-B2 Antifungal agent containing heterocyclic compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2011-04-26 US disclosed
US-7932272-B2 Antifungal agent containing heterocyclic compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2011-04-26 US disclosed
US-7932272-B2 Antifungal agent containing heterocyclic compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2011-04-26 US disclosed
US-20090227799-A1 Novel Antimalarial Agent Containing Heterocyclic Compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-09-10 US disclosed
US-7541466-B2 Tetrahydroisoquinoline derivatives for treating protein trafficking diseases GENZYME CORPORATION (US) 2009-06-02 US disclosed
US-20070105943-A1 Novel antifungal agent containing heterocyclic compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2007-05-10 US disclosed
US-20070105943-A1 Novel antifungal agent containing heterocyclic compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2007-05-10 US disclosed
US-20070105943-A1 Novel antifungal agent containing heterocyclic compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2007-05-10 US disclosed
EP-1782811-A1 NOVEL ANTIMALARIA AGENT CONTAINING HETEROCYCLIC COMPOUND Eisai R&D Management Co., Ltd. (JP) 2007-05-09 EP disclosed
EP-1669348-A1 NOVEL ANTIFUNGAL AGENT COMPRISING HETEROCYCLIC COMPOUND Eisai Co., Ltd. (JP) 2006-06-14 EP disclosed
US-4327109-A INSECTICIDES SUMITOMO CHEMICAL COMPANY LIMITED (JP) 1982-04-27 US disclosed
US-4229469-A Insecticidal alkadienylcyclopropanecarboxylates SUMITOMO CHEMICAL COMPANY LIMITED (JP) 1980-10-21 US disclosed
US-3998868-A INSECTICIDES SUMITOMO CHEMICAL COMPANY, LIMITED (JA) 1976-12-21 US disclosed
US-3954814-A INSECTICIDES SUMITOMO CHEMICAL COMPANY, LIMITED (JA) 1976-05-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110195999-A1 NOVEL ANTIFUNGAL AGENT CONTAINING HETEROCYCLIC COMPOUND ERG28, CYP51A1, XPO1 HTR2C 3077/4885HTR6 4269/4885TSHR 3875/4885
US-20090227799-A1 Novel Antimalarial Agent Containing Heterocyclic Compound XPO1, THPO, G6PD HTR2C 2944/4885HTR6 2973/4885TSHR 3836/4885
US-20070105943-A1 Novel antifungal agent containing heterocyclic compound ERG28, DPM1, CYP51A1 HTR2C 3152/4885HTR6 4266/4885TSHR 3952/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.